Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364572 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Epidural Etanercept in the Treatment of Sciatica
A Phase 1 study of Sciatica, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00364572 is a Phase 1 study of Sciatica that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants, below the 83-participant average among 6 other Sciatica trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00364572, a Phase 1 study of Sciatica, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Tumor necrosis factor (TNF)-alpha has been strongly implicated as a major contributing factor for the development of radiculopathy. In animal studies, the application of TNF-alpha to nerve roots results in pain behavior indicative of radiculopathy. The use of TNF-alpha inhibitors (etanercept and infliximab) have been shown to prevent this pain behavior. Open-label studies in humans have shown both etanercept and infliximab provide excellent, long-term relief in patients with acute radiculopathy from herniated disc. However, a recent placebo-controlled study failed to demonstrate any significant difference from placebo. The investigators have already established the safety of neuraxial etanercept in a trial that has just been completed (not yet published). The objective of this study is to determine whether small doses of epidural etanercept, an anti-TNF-a medication, is an effective treatment for LBP caused by nerve root irritation (i.e., radiculopathy).
Conditions Studied
Interventions
- DRUG epidural injection of etanercept
- DRUG placebo (control procedure)
Study Locations (1)
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00364572
The ClinicalTrials.gov registry entry for NCT00364572 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 6 other Sciatica trials with a reported enrollment target (71% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sciatica appearing as the primary indexed condition, and to 2 interventions - of which epidural injection of etanercept is the first listed.
NCT00364572 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00364572 about?
NCT00364572 is a clinical study titled "Efficacy of Epidural Etanercept in the Treatment of Sciatica". Tumor necrosis factor (TNF)-alpha has been strongly implicated as a major contributing factor for the development of radiculopathy. In animal studies, the application of TNF-alpha to nerve roots results in pain behavior indicative of radiculopathy. The use of TNF-alpha inhibitors (etanercept and inf...
What is the current status of trial NCT00364572?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2006-05. Estimated completion is 2007-12.
What conditions does trial NCT00364572 study?
This clinical trial studies the following conditions: Sciatica.
What interventions are being tested in trial NCT00364572?
The interventions under investigation include: epidural injection of etanercept (DRUG), placebo (control procedure) (DRUG).
Who is sponsoring clinical trial NCT00364572?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00364572 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sciatica
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation
COMPLETED · Phase 1
-
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
RECRUITING · NA
-
The Efficacy of Oral Steroids in the Treatment of Acute Sciatica
COMPLETED · Phase 3
-
Magnets in the Treatment of Sciatica
COMPLETED · Phase 2
-
Pain Treatment for Sciatica
COMPLETED · Phase 2
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.